Pesquisas alternativas:
confer disease » confers disease (Expandir a Pesquisa), cancer disease (Expandir a Pesquisa), canker disease (Expandir a Pesquisa)
company series » company denies (Expandir a Pesquisa), compound series (Expandir a Pesquisa), complex series (Expandir a Pesquisa)
disease newly » disease new (Expandir a Pesquisa), disease newer (Expandir a Pesquisa), disease news (Expandir a Pesquisa)
complex trad » complex trait (Expandir a Pesquisa), complex trial (Expandir a Pesquisa), complex trans (Expandir a Pesquisa)
nail company » rail company (Expandir a Pesquisa), oil company (Expandir a Pesquisa), aid company (Expandir a Pesquisa)
far complex » par complex (Expandir a Pesquisa), tar complex (Expandir a Pesquisa), scar complex (Expandir a Pesquisa)
trad ngoc » tran ngoc (Expandir a Pesquisa), tram ngoc (Expandir a Pesquisa), tra ngoc (Expandir a Pesquisa)
l confer » l confers (Expandir a Pesquisa), _ confer (Expandir a Pesquisa), i confer (Expandir a Pesquisa)
3 nail » _ nail (Expandir a Pesquisa), a nail (Expandir a Pesquisa), 3 nacl (Expandir a Pesquisa)
5 far » _ far (Expandir a Pesquisa), a far (Expandir a Pesquisa), 5 fam (Expandir a Pesquisa)
confer disease » confers disease (Expandir a Pesquisa), cancer disease (Expandir a Pesquisa), canker disease (Expandir a Pesquisa)
company series » company denies (Expandir a Pesquisa), compound series (Expandir a Pesquisa), complex series (Expandir a Pesquisa)
disease newly » disease new (Expandir a Pesquisa), disease newer (Expandir a Pesquisa), disease news (Expandir a Pesquisa)
complex trad » complex trait (Expandir a Pesquisa), complex trial (Expandir a Pesquisa), complex trans (Expandir a Pesquisa)
nail company » rail company (Expandir a Pesquisa), oil company (Expandir a Pesquisa), aid company (Expandir a Pesquisa)
far complex » par complex (Expandir a Pesquisa), tar complex (Expandir a Pesquisa), scar complex (Expandir a Pesquisa)
trad ngoc » tran ngoc (Expandir a Pesquisa), tram ngoc (Expandir a Pesquisa), tra ngoc (Expandir a Pesquisa)
l confer » l confers (Expandir a Pesquisa), _ confer (Expandir a Pesquisa), i confer (Expandir a Pesquisa)
3 nail » _ nail (Expandir a Pesquisa), a nail (Expandir a Pesquisa), 3 nacl (Expandir a Pesquisa)
5 far » _ far (Expandir a Pesquisa), a far (Expandir a Pesquisa), 5 fam (Expandir a Pesquisa)
1
Por Keller, J, Nimnual, A S, Shroyer, K R, Joy, C, Ischenko, I, Chandler, C S, Dong, L M, Hayman, M J, Chan, E L
Publicado em 2013
“... EGFR (pEGFR). Newly diagnosed HNSCC with either Ron/pEGFR or both had lower disease-free survival than...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Kim, Victor, Zhao, Huaqing, Boriek, Aladin M., Anzueto, Antonio, Soler, Xavier, Bhatt, Surya P., Rennard, Stephen I., Wise, Robert, Comellas, Alejandro, Ramsdell, Joe W., Kinney, Gregory L., Han, MeiLan K., Martinez, Carlos H., Yen, Andrew, Black-Shinn, Jennifer, Porszasz, Janos, Criner, Gerard J., Hanania, Nicola A., Sharafkhaneh, Amir, Crapo, James D., Make, Barry J., Silverman, Edwin K., Curtis, Jeffrey L.
Publicado no Ann Am Thorac Soc (2016)
“... an OR of 2.621 (95% CI, 1.677–4.096) and 5.767 (95% CI, 3.702–8.983) for subjects with new chronic bronchitis...”Publicado no Ann Am Thorac Soc (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
Por Pruzin, Jeremy J., Nelson, Peter T., Abner, Erin L., Arvanitakis, Zoe
Publicado no Neuropathol Appl Neurobiol (2018)
“...Type 2 diabetes (T2D) and Alzheimer disease (AD) are both highly prevalent diseases worldwide...”Publicado no Neuropathol Appl Neurobiol (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por Chow, Eric J., Wong, Kenneth, Lee, Stephanie J., Cushing-Haugen, Kara L., Flowers, Mary E.D., Friedman, Debra L., Leisenring, Wendy M., Martin, Paul J., Mueller, Beth A., Baker, K. Scott
Publicado em 2014
“..., and all-cause cardiovascular death was 3.8%, 6.0%, 3.5%, and 3.7%, respectively. In multivariable analysis...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por Braskie, Meredith N., Jahanshad, Neda, Stein, Jason L., Barysheva, Marina, McMahon, Katie L., de Zubicaray, Greig I., Martin, Nicholas G., Wright, Margaret J., Ringman, John M., Toga, Arthur W., Thompson, Paul M.
Publicado em 2011
“...There is a strong genetic risk for late-onset Alzheimer's disease (AD), but so far few gene...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por L. Huang, S. Tepaamorndech, C. P. Kirschke, Y. Cai, J. Zhao, Xiaohan Cao, Andrew Rao
Publicado em 2019-02-01
“...7-KO) and their wild type littermates in a mixed 129P1/ReJ (129P1) and C57BL/6J (B6) background...”Publicado em 2019-02-01
Obter o texto integral
Artigo
7
Por Huang, L., Tepaamorndech, S., Kirschke, C. P., Cai, Y., Zhao, J., Cao, Xiaohan, Rao, Andrew
Publicado no BMC Genet (2019)
“...) and their wild type littermates in a mixed 129P1/ReJ (129P1) and C57BL/6J (B6) background identified a...”Publicado no BMC Genet (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Spevacek, Ann R., Evans, Eric G. B., Miller, Jillian L., Meyer, Heidi C., Pelton, Jeffrey G., Millhauser, Glenn L.
Publicado em 2013
“... in this interaction carries the majority of the point mutations that confer familial prion disease. Investigation...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Lee, Albert, Rayner, Stephanie L., De Luca, Alana, Gwee, Serene S. L., Morsch, Marco, Sundaramoorthy, Vinod, Shahheydari, Hamideh, Ragagnin, Audrey, Shi, Bingyang, Yang, Shu, Williams, Kelly L., Don, Emily K., Walker, Adam K., Zhang, Katharine Y., Yerbury, Justin J., Cole, Nicholas J., Atkin, Julie D., Blair, Ian P., Molloy, Mark P., Chung, Roger S.
Publicado no Open Biol (2017)
“... by progressive weakness, paralysis and muscle loss often resulting in patient death within 3–5 years of diagnosis...”Publicado no Open Biol (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Gudmundsson, Julius, Sulem, Patrick, Rafnar, Thorunn, Bergthorsson, Jon T, Manolescu, Andrei, Gudbjartsson, Daniel, Agnarsson, Bjarni A, Sigurdsson, Asgeir, Benediktsdottir, Kristrun R, Blondal, Thorarinn, Jakobsdottir, Margret, Stacey, Simon N, Kostic, Jelena, Kristinsson, Kari T, Birgisdottir, Birgitta, Ghosh, Shyamali, Magnusdottir, Droplaug N, Thorlacius, Steinunn, Thorleifsson, Gudmar, Zheng, S Lilly, Sun, Jielin, Chang, Bao-Li, Elmore, J Bradford, Breyer, Joan P, McReynolds, Kate M, Bradley, Kevin M, Yaspan, Brian L, Wiklund, Fredrik, Stattin, Par, Lindström, Sara, Adami, Hans-Olov, McDonnell, Shannon K, Schaid, Daniel J, Cunningham, Julie M, Wang, Liang, Cerhan, James R, St Sauver, Jennifer L, Isaacs, Sara D, Wiley, Kathleen E, Partin, Alan W, Walsh, Patrick C, Polo, Sonia, Ruiz-Echarri, Manuel, Navarrete, Sebastian, Fuertes, Fernando, Saez, Berta, Godino, Javier, Weijerman, Philip C, Swinkels, Dorine W, Aben, Katja K, Witjes, J Alfred, Suarez, Brian K, Helfand, Brian T, Frigge, Michael L, Kristjansson, Kristleifur, Ober, Carole, Jonsson, Eirikur, Einarsson, Gudmundur V, Xu, Jianfeng, Gronberg, Henrik, Smith, Jeffrey R, Thibodeau, Stephen N, Isaacs, William B, Catalona, William J, Mayordomo, Jose I, Kiemeney, Lambertus A, Barkardottir, Rosa B, Gulcher, Jeffrey R, Thorsteinsdottir, Unnur, Kong, Augustine, Stefansson, Kari
Publicado em 2008
“... newly identified variants were shown to be associated with prostate cancer: rs5945572 on Xp11.22 and rs...”Publicado em 2008
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Taber, Jennifer M., Klein, William M.P., Lewis, Katie L., Johnston, Jennifer J., Biesecker, Leslie G., Biesecker, Barbara B.
Publicado no Genet Med (2017)
“... variant that was reclassified as benign. Positive testers (n=19) had a newly-identified causative variant...”Publicado no Genet Med (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por Gilman, Andrew L., Schultz, Kirk R., Goldman, Frederick D., Sale, George E., Krailo, Mark D., Chen, Zhengjia, Langholz, Bryan, Jacobsohn, David A., Chan, Ka-Wah, Ryan, Robin E., Kellick, Michael, Neudorf, Steven M., Godder, Kamar, Sandler, Eric S., Sahdev, Indira, Grupp, Stephan A., Sanders, Jean E., Wall, Donna A.
Publicado no Biol Blood Marrow Transplant (2011)
“...The Children’s Oncology Group conducted a multi-center Phase III trial for chronic GVHD (cGVHD...”Publicado no Biol Blood Marrow Transplant (2011)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
Por Pottie, Kevin, Mayhew, Alain D, Morton, Rachael L, Greenaway, Christina, Akl, Elie A, Rahman, Prinon, Zenner, Dominik, Pareek, Manish, Tugwell, Peter, Welch, Vivian, Meerpohl, Joerg, Alonso-Coello, Pablo, Hui, Charles, Biggs, Beverley-Ann, Requena-Méndez, Ana, Agbata, Eric, Noori, Teymur, Schünemann, Holger J
Publicado no BMJ Open (2017)
Assuntos:
“...Infectious Diseases...”Publicado no BMJ Open (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Kawabata, Shigeru, Chiang, Chun-Te, Tsurutani, Junji, Shiga, Hideaki, Arwood, Matthew L., Komiya, Takefumi, Gills, Joell J., Memmott, Regan M., Dennis, Phillip A.
Publicado em 2014
“... of newly diagnosed patients have metastatic disease. Pemetrexed is a widely used drug for NSCLC...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Artigo
15
Por Mulrooney, Daniel A., Armstrong, Gregory T., Huang, Sujuan, Ness, Kirsten K., Ehrhardt, Matthew J., Joshi, Vijaya M., Plana, Juan Carlos, Soliman, Elsayed Z., Green, Daniel M., Srivastava, Deokumar, Santucci, Aimee, Krasin, Matthew J., Robison, Leslie L., Hudson, Melissa M.
Publicado no Ann Intern Med (2016)
“... at the time of evaluation in 4.7%), coronary artery disease (CAD) in 3.8% (newly identified in 2.2%), valvular...”Publicado no Ann Intern Med (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Por Paugh, Steven W., Bonten, Erik J., Savic, Daniel, Ramsey, Laura B., Thierfelder, William E., Gurung, Prajwal, Malireddi, R. K. Subbarao, Actis, Marcelo, Mayasundari, Anand, Min, Jaeki, Coss, David R., Laudermilk, Lucas T., Panetta, John C., McCorkle, J. Robert, Fan, Yiping, Crews, Kristine R., Stocco, Gabriele, Wilkinson, Mark R., Ferreira, Antonio M., Cheng, Cheng, Yang, Wenjian, Karol, Seth E., Fernandez, Christian A., Diouf, Barthelemy, Smith, Colton, Hicks, J. Kevin, Zanut, Alessandra, Giordanengo, Audrey, Crona, Daniel, Bianchi, Joy J., Holmfeldt, Linda, Mullighan, Charles G., den Boer, Monique L., Pieters, Rob, Jeha, Sima, Dunwell, Thomas L., Latif, Farida, Bhojwani, Deepa, Carroll, William L., Pui, Ching-Hon, Myers, Richard M., Guy, R. Kiplin, Kanneganti, Thirumala-Devi, Relling, Mary V., Evans, William E.
Publicado no Nat Genet (2015)
“... resistance in CASP1 overexpressing ALL. Our findings establish a new mechanism by which the NLRP3/CASP1...”Publicado no Nat Genet (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Kircher, David A., Silvis, Mark R., Cho, Joseph H., Holmen, Sheri L.
Publicado no Int J Mol Sci (2016)
“... cause significant morbidity and mortality and confer a poor prognosis; traditional therapies including...”Publicado no Int J Mol Sci (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Rodrigues, George, Yao, Xiaomei, Loblaw, D. Andrew, Brundage, Michael, Chin, Joseph L.
Publicado em 2013
“..., relevant guideline web-sites, and websites for meetings specific for genitourinary diseases. RESULTS: Ten...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por Fernandes, Neil, Case, Rebecca J., Longford, Sharon R., Seyedsayamdost, Mohammad R., Steinberg, Peter D., Kjelleberg, Staffan, Thomas, Torsten
Publicado em 2011
“...Nautella sp. R11, a member of the marine Roseobacter clade, causes a bleaching disease...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations
Por Milner, Joshua D., Vogel, Tiphanie P., Forbes, Lisa, Ma, Chi A., Stray-Pedersen, Asbjørg, Niemela, Julie E., Lyons, Jonathan J., Engelhardt, Karin R., Zhang, Yu, Topcagic, Nermina, Roberson, Elisha D. O., Matthews, Helen, Verbsky, James W., Dasu, Trivikram, Vargas-Hernandez, Alexander, Varghese, Nidhy, McClain, Kenneth L., Karam, Lina B., Nahmod, Karen, Makedonas, George, Mace, Emily M., Sorte, Hanne S., Perminow, Gøri, Rao, V. Koneti, O’Connell, Michael P., Price, Susan, Su, Helen C., Butrick, Morgan, McElwee, Joshua, Hughes, Jason D., Willet, Joseph, Swan, David, Xu, Yaobo, Santibanez-Koref, Mauro, Slowik, Voytek, Dinwiddie, Darrell L., Ciaccio, Christina E., Saunders, Carol J., Septer, Seth, Kingsmore, Stephen F., White, Andrew J., Cant, Andrew J., Hambleton, Sophie, Cooper, Megan A.
Publicado no Blood (2015)
“... demonstrate that these mutations confer a gain-of-function in STAT3 leading to secondary defects in STAT5...”Publicado no Blood (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo